Financial reports
10-K
2023 FY
Annual report
8 Mar 24
10-Q
2023 Q3
Quarterly report
1 Nov 23
10-Q
2023 Q2
Quarterly report
11 Aug 23
10-Q
2023 Q1
Quarterly report
15 May 23
10-K
2022 FY
Annual report
31 Mar 23
10-Q
2022 Q3
Quarterly report
14 Nov 22
10-Q
2022 Q2
Quarterly report
5 Aug 22
10-Q
2022 Q1
Quarterly report
12 May 22
10-K/A
2021 FY
Annual report (amended)
29 Apr 22
Current reports
8-K
Alimera Sciences Reports Fourth Quarter and Full Year 2023 Results
7 Mar 24
8-K
Departure of Directors or Certain Officers
9 Feb 24
8-K
Departure of Directors or Certain Officers
4 Jan 24
8-K
Departure of Directors or Certain Officers
12 Dec 23
8-K
Alimera Appoints Maggie A. Pax to Its Board of Directors
8 Nov 23
8-K
Alimera Sciences Reports Third Quarter 2023 Results
26 Oct 23
8-K
Alimera Sciences Appoints Jason Werner as Chief Operating Officer
3 Oct 23
8-K
Unregistered Sales of Equity Securities
15 Aug 23
8-K
Alimera Sciences Reports Second Quarter 2023 Results
10 Aug 23
8-K
Unregistered Sales of Equity Securities
2 Aug 23
Registration and prospectus
S-8
Registration of securities for employees
8 Mar 24
S-8
Registration of securities for employees
9 Feb 24
S-8
Registration of securities for employees
9 Feb 24
S-8
Registration of securities for employees
11 Aug 23
424B3
Prospectus supplement
1 Aug 23
424B3
Prospectus supplement
12 Jul 23
S-3
Shelf registration
30 Jun 23
D/A
$81.00 mm in equity / options / securities to be acquired, sold $81.00 mm, 16 investors
31 May 23
S-8
Registration of securities for employees
28 Apr 23
D
$27.00 mm in equity / options / securities to be acquired, sold $12.00 mm, 4 investors
7 Apr 23
Proxies
DEF 14A
Definitive proxy
29 Jun 23
PRE 14A
Preliminary proxy
15 Jun 23
DEFA14A
Additional proxy soliciting materials
27 Mar 23
DEFA14A
Additional proxy soliciting materials
1 Jun 22
DEF 14A
Definitive proxy
1 Jun 22
DEFA14A
Additional proxy soliciting materials
1 Jun 21
DEFA14A
Additional proxy soliciting materials
30 Apr 21
DEF 14A
Definitive proxy
30 Apr 21
DEFA14A
Additional proxy soliciting materials
29 Apr 20
DEF 14A
Definitive proxy
29 Apr 20
Other
EFFECT
Notice of effectiveness
12 Jul 23
UPLOAD
Letter from SEC
10 Jul 23
CORRESP
Correspondence with SEC
10 Jul 23
EFFECT
Notice of effectiveness
12 Nov 20
UPLOAD
Letter from SEC
4 Nov 20
CORRESP
Correspondence with SEC
4 Nov 20
SEC STAFF LETTER
SEC staff letter
18 Mar 20
SEC STAFF
SEC staff action: Order
19 Feb 20
CT ORDER
Confidential treatment order
29 Jan 18
EFFECT
Notice of effectiveness
3 Nov 17
Ownership
4
Jason M. Werner
13 Mar 24
4
Todd Michael Wood
13 Mar 24
4
RICHARD S EISWIRTH JR
13 Mar 24
4
Philip Ashman
13 Mar 24
4
Elliot Maltz
13 Mar 24
SC 13G/A
LYTTON LAURENCE W
14 Feb 24
SC 13G/A
BOOTHBAY FUND MANAGEMENT, LLC
13 Feb 24
SC 13G/A
Stonepine Capital Management, LLC
13 Feb 24
SC 13G/A
HBM Healthcare Investments (Cayman) Ltd.
13 Feb 24
SC 13G/A
Altium Capital Management LP
13 Feb 24